Farkas Gyula, Hofner Peter, Balog Attila, Takács Tamas, Szabolcs Annamaria, Farkas Gyula, Mándi Yvette
Department of Surgery, University of Szeged, Hungary.
Eur Cytokine Netw. 2007 Mar;18(1):31-7. doi: 10.1684/ecn.2007.0084. Epub 2007 Mar 30.
Cytokine regulation may be an important factor in the susceptibility for the development of chronic pancreatitis; transforming growth factor-beta1 (TGF-beta1) plays a central role in the pathogenesis of pancreatic fibrogenesis. The aim of our study was to analyse the relevance of TGF-beta1, interleukin-8 (IL-8) and tumor necrosis factor-alpha (TNF-alpha) polymorphisms in patients with chronic pancreatitis.
of the 83 patients enrolled in the study, 43 were treated medically and 40 patients underwent surgical intervention. Healthy blood donors (n=75) served as controls.
the polymorphisms of TGF-beta1 +869 T--> C and IL-8 -251 T-->A were determined by the ARMS method, while that of TNF-alpha -308 was investigated using NcoI RFLP.
there was a higher frequency (50%) of the TT genotype of TGF-beta1 +869, with a concomitantly higher TGF-beta1 level in the plasma (5.2 +/- 1.7 ng/mL) of patients with chronic pancreatitis than in healthy blood donors (28% and 2.8 +/- 0.9 ng/mL respectively). The number of TT homozygotes differed significantly between the patients who underwent surgical intervention and the controls, and even between the surgical and the non-surgical patients. The frequency of the T/A genotype with higher IL-8 production, was significantly higher in both groups of patients than in the controls (58% and 58% versus 40%). No correlation was found between the TNF-alpha -308 polymorphism and chronic pancreatitis.
correlations of the TGF-beta1 and IL-8 single nucleotide polymorphisms (SNPs) with chronic pancreatitis underline the importance of these cytokines in the pathomechanism of the disease. Moreover, it seems that the TT genotype of +869 TGF-beta1 might be a risk factor for the development of a severe form of chronic pancreatitis, and could serve as a prognostic sign for any future surgical intervention or even repeat surgery. Further studies on a larger group of patients, in addition to a follow-up study, are necessary to confirm this preliminary observation.
细胞因子调节可能是慢性胰腺炎易感性的一个重要因素;转化生长因子-β1(TGF-β1)在胰腺纤维化发病机制中起核心作用。我们研究的目的是分析TGF-β1、白细胞介素-8(IL-8)和肿瘤坏死因子-α(TNF-α)基因多态性与慢性胰腺炎患者的相关性。
本研究纳入的83例患者中,43例接受药物治疗,40例接受手术干预。健康献血者(n = 75)作为对照。
采用扩增阻滞突变系统(ARMS)法检测TGF-β1 +869 T→C和IL-8 -251 T→A的基因多态性,采用NcoI限制性片段长度多态性(RFLP)法检测TNF-α -308的基因多态性。
慢性胰腺炎患者中TGF-β1 +869的TT基因型频率较高(50%),其血浆中TGF-β1水平(5.2±1.7 ng/mL)也高于健康献血者(分别为28%和2.8±0.9 ng/mL)。接受手术干预的患者与对照组之间,甚至手术患者与非手术患者之间,TT纯合子数量差异显著。两组患者中产生较高IL-8的T/A基因型频率均显著高于对照组(分别为58%、58%和40%)。未发现TNF-α -308基因多态性与慢性胰腺炎之间存在相关性。
TGF-β1和IL-8单核苷酸多态性(SNP)与慢性胰腺炎的相关性强调了这些细胞因子在疾病发病机制中的重要性。此外,似乎+869 TGF-β1的TT基因型可能是重症慢性胰腺炎发生的危险因素,可作为未来任何手术干预甚至再次手术的预后指标。需要对更大规模的患者群体进行进一步研究,并进行随访研究,以证实这一初步观察结果。